DK1907536T3 - Cellelinie til produktion af coronavira - Google Patents

Cellelinie til produktion af coronavira

Info

Publication number
DK1907536T3
DK1907536T3 DK06792538.8T DK06792538T DK1907536T3 DK 1907536 T3 DK1907536 T3 DK 1907536T3 DK 06792538 T DK06792538 T DK 06792538T DK 1907536 T3 DK1907536 T3 DK 1907536T3
Authority
DK
Denmark
Prior art keywords
coronaviruses
production
cell line
relates
cov
Prior art date
Application number
DK06792538.8T
Other languages
English (en)
Inventor
Den Brink Edward Norbert Van
Meulen Jan Henrik Ter
Original Assignee
Crucell Holland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holland Bv filed Critical Crucell Holland Bv
Application granted granted Critical
Publication of DK1907536T3 publication Critical patent/DK1907536T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20051—Methods of production or purification of viral material
    • C12N2770/20052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK06792538.8T 2005-07-22 2006-07-21 Cellelinie til produktion af coronavira DK1907536T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70202905P 2005-07-22 2005-07-22
EP05106768 2005-07-22
PCT/EP2006/064489 WO2007010028A1 (en) 2005-07-22 2006-07-21 Cell line for producing coronaviruses

Publications (1)

Publication Number Publication Date
DK1907536T3 true DK1907536T3 (da) 2010-07-19

Family

ID=35445861

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06792538.8T DK1907536T3 (da) 2005-07-22 2006-07-21 Cellelinie til produktion af coronavira

Country Status (10)

Country Link
US (1) US7888102B2 (da)
EP (1) EP1907536B1 (da)
JP (1) JP5137829B2 (da)
KR (1) KR101274790B1 (da)
CN (1) CN101228267B (da)
AT (1) ATE463559T1 (da)
AU (1) AU2006271666B2 (da)
CA (1) CA2616221C (da)
DK (1) DK1907536T3 (da)
WO (1) WO2007010028A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG128680A1 (en) * 2003-07-22 2007-01-30 Crucell Holland Bv Binding molecules against sars-coronavirus and uses thereof
EP1907536B1 (en) 2005-07-22 2010-04-07 Crucell Holland B.V. Cell line for producing coronaviruses
EP2059532B1 (en) 2006-09-07 2012-12-26 Crucell Holland B.V. Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
CN111273016B (zh) * 2020-02-26 2021-06-15 浙江诺迦生物科技有限公司 一种基于s蛋白配体与ace2受体竞争法层析的冠状病毒快速检测的试剂盒
WO2021207303A1 (en) * 2020-04-07 2021-10-14 Alsatech, Inc. Immune stimulation against coronavirus infections
US12194157B2 (en) 2020-04-09 2025-01-14 Finncure Oy Carrier for targeted delivery to a host
AU2021252164A1 (en) 2020-04-09 2022-12-15 Finncure Oy Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses
US12570700B2 (en) 2020-04-17 2026-03-10 Regents Of The University Of Minnesota SARS-CoV-2 spike receptor binding domain and compositions and methods thereof
WO2021214467A1 (en) * 2020-04-23 2021-10-28 Cellbio A diagnostic tool improvement comprising a pathogen binding molecule
CN111575242A (zh) * 2020-06-04 2020-08-25 广东源心再生医学有限公司 一种用于COVID-19药物筛选的iPSC-nCoVN细胞模型及其建立和使用方法
US12156908B2 (en) 2020-07-01 2024-12-03 Regents Of The University Of Minnesota Virus like nanoparticle compositions and methods thereof
CN116710560A (zh) * 2020-08-21 2023-09-05 西湖大学 工程化ace2寡聚物及其用途
US20220226489A1 (en) 2021-01-20 2022-07-21 Singh Biotechnology, Llc Therapeutics directed against coronavirus

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100470180B1 (ko) * 1995-06-15 2005-02-04 크루셀 홀란드 비.브이. 유전자 요법에 사용할 수 있는 인간의 재조합아데노바이러스 패키징 시스템
US6855544B1 (en) * 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
ES2372823T3 (es) 1999-05-17 2012-01-26 Crucell Holland B.V. Adenovirus recombinante del serotipo ad11.
EP1103610A1 (en) * 1999-11-26 2001-05-30 Introgene B.V. Production of vaccines from immortalised mammalian cell lines
WO2004042042A1 (en) * 2002-11-08 2004-05-21 Crucell Holland B.V. Vaccines against west nile virus
FR2828405B1 (fr) 2001-08-09 2005-06-24 Virbac Sa Vaccin anti-coronavirus
EP1633775A2 (en) 2003-06-13 2006-03-15 Crucell Holland B.V. Antigenic peptides of sars coronavirus and uses thereof
WO2005012337A2 (en) 2003-07-15 2005-02-10 Crucell Holland B.V. Antigenic peptides of sars coronavirus and uses thereof
EP1646645A1 (en) 2003-07-21 2006-04-19 Crucell Holland B.V. Antigenic peptides of sars coronavirus and uses thereof
SG128680A1 (en) 2003-07-22 2007-01-30 Crucell Holland Bv Binding molecules against sars-coronavirus and uses thereof
WO2005047459A2 (en) * 2003-08-04 2005-05-26 University Of Massachusetts Sars nucleic acids, proteins, antibodies, and uses thereof
US20050282154A1 (en) * 2003-10-06 2005-12-22 The Brigham And Women's Hospital, Inc. Angiotensin-converting enzyme-2 as a receptor for the SARS coronavirus
EP1907536B1 (en) 2005-07-22 2010-04-07 Crucell Holland B.V. Cell line for producing coronaviruses

Also Published As

Publication number Publication date
EP1907536A1 (en) 2008-04-09
KR101274790B1 (ko) 2013-06-13
WO2007010028A1 (en) 2007-01-25
US7888102B2 (en) 2011-02-15
AU2006271666B2 (en) 2011-04-07
JP2009502128A (ja) 2009-01-29
US20090098530A1 (en) 2009-04-16
KR20080033270A (ko) 2008-04-16
CN101228267A (zh) 2008-07-23
CA2616221A1 (en) 2007-01-25
EP1907536B1 (en) 2010-04-07
CA2616221C (en) 2011-07-05
ATE463559T1 (de) 2010-04-15
CN101228267B (zh) 2013-01-23
AU2006271666A1 (en) 2007-01-25
JP5137829B2 (ja) 2013-02-06

Similar Documents

Publication Publication Date Title
WO2010088633A3 (en) Novel cell lines and methods
WO2009039307A3 (en) Hydrogels and methods for producing and using the same
IL229348B (en) Methods for producing activated dendritic cells
NL1026467A1 (nl) Composiet semipermeabel membraan, alsmede productiewerkwijze daarvoor.
WO2009102569A3 (en) Cell lines and methods for making and using them
WO2008021156A3 (en) Antibodies to il-17a
CY1113985T1 (el) Μεθοδοι παραγωγης κυκλοαλκυλκαρβοξυαμιδο-πυριδινο βενζοϊκων οξεων
DK1828065T3 (da) Fremgangsmåde til øget fremstilling af biogas i termofile, anaerobe fermentorer
DK3081649T3 (da) Mikroorganisme, der producerer l-methionin-prækursor, og fremgangsmåden til produktion af l-methionin-prækursor ved anvendelse af mikroorganismen
EP2586611A4 (en) POROUS COMPOSITE MEMBRANE, METHOD FOR PRODUCING A POROUS COMPOUND MEMBRANE AND BATTERY SUBSTANCE THEREWITH
WO2010078952A3 (de) Strukturierte gasdiffusionselektrode für elektrolysezellen
DK2174371T3 (da) Fremgangsmåde til fremstilling af en brændselscelle
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
DE602007006258D1 (de) Ionenaustausch-Membranelektrolyseur
WO2008047113A3 (en) Ethanol production
ATE463559T1 (de) Zelllinie zur produktion von coronaviren
DK1851815T3 (da) Fremgangsmåde til fremstilling af en brændselscellekatode
DE602005003581D1 (de) Elektrolysezelle
DE602005024180D1 (de) Erzeugungssystem für brennstoffzellen des polymer-elektrolyttyps
DK1976960T3 (da) Fremgangsmåde til fremstilling af biodiesel
MX2012003488A (es) Proceso para la elaboracion de n-acil-bifenil-alanina.
DK2147133T3 (da) Elektrode til membranelektrolyseceller
DE602006014676D1 (de) Festpolymerelektrolyt-membran, herstellungsverfahren dafür und brennstoffzelle
BRPI0918870A2 (pt) método para produzir álcool, método para produzir hidrogênio ou gás de síntese usando o método para produzir álcool, e álcool.
PL2300606T3 (pl) Sposób wytwarzania hydrolizatu kazeiny